News
-
-
-
-
COMMUNIQUÉ DE PRESSE
EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DU TEST GÉNOMIQUE ENDOPREDICT® AUPRÈS DE MYRIAD GENETICS
Eurobio Scientific finalise l’acquisition du test génomique EndoPredict® auprès de Myriad Genetics, renforçant son leadership dans le diagnostic médical in vitro. Pour plus d'informations, visitez www.eurobio-scientific.com -
-
-
-
-
COMMUNIQUÉ DE PRESSE
EUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO FILE A VOLUNTARY TENDER OFFER AT A PRICE
Eurobio Scientific announces a voluntary tender offer at €25.30 per share led by a consortium including NextStage AM and IK Partners, aiming at accelerating the company's growth plan -
COMMUNIQUÉ DE PRESSE
Eurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER
Eurobio Scientific reports a strong start to the financial year with a +24% revenue growth in H1 2024. Proposed tender offer led by consortium for voluntary shares acquisition